Assembly Biosciences, Inc. (ASMB) vs Ovid Therapeutics Inc. (OVID)
A side-by-side comparison of Assembly Biosciences, Inc. and Ovid Therapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ASMB
Assembly Biosciences, Inc.
$21.97HealthcareDelayed quote: Oct 6, 2026, 1:50 PM EDT
OVID
Ovid Therapeutics Inc.
$2.38HealthcareDelayed quote: Oct 6, 2026, 1:50 PM EDT
Total return — ASMB vs OVID
growth of $100 · dividends reinvested · last 9yASMB -92.1% (-24.6%/yr)OVID -80.9% (-16.8%/yr)OVID compounded faster over this window
ASMB OVID
ASMB vs OVID: by the numbers
- •OVID is the larger company ($445M vs $435M market cap).
- •Both run net losses; ASMB's is the smaller (-0.06% vs -2178.90% net margin).
- •Both shrank revenue over the past five years; ASMB's decline was smaller (-1.78% vs -62.76% CAGR).
Metrics side by side
Valuation
| Metric | ASMB | OVID |
|---|---|---|
| P/E ratio | 39.95 | N/A |
| P/S ratio | 5.82 | 280.92 |
| P/B ratio | 1.42 | 2.12 |
Profitability
| Metric | ASMB | OVID |
|---|---|---|
| Gross margin | 99.82% | 100.00% |
| Operating margin | -11.75% | -585.20% |
| Net margin | -0.06% | -2178.90% |
| ROE | -0.01% | -16.43% |
| ROIC | -2.86% | -26.29% |
Growth (annualized)
| Metric | ASMB | OVID |
|---|---|---|
| Revenue CAGR (5Y) | -1.78% | -62.76% |
| Total return CAGR (5Y) | -10.66% | -6.98% |
Frequently asked
- Which has grown faster, ASMB or OVID?
- Neither grew: over the past five years both shrank revenue, with ASMB's decline the smaller — ASMB at a -1.78% CAGR versus OVID at -62.76%.
- How have ASMB and OVID total returns compared?
- Over the past 5 years, ASMB delivered -10.66% and OVID delivered -6.98% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.